Whether it is new and groundbreaking research results, university topics or events – in our press releases you can find everything you need to know about the happenings at 51ÁÔÆæ. To subscribe, just send an email to ott@pvw.uni-frankfurt.de
Theodor-W.-Adorno Platz 1
60323 Frankfurt
presse@uni-frankfurt.de
New international study generates insights into the inner workings of the adaptive immune response
How do killer T cells recognise cells in the body that have been infected by viruses? Matter foreign to the body is presented on the surface of these cells as antigens that act as a kind of road sign. A network of accessory proteins – the chaperones – ensure that this sign retains its stability over time. Researchers at Goethe University have now reached a comprehensive understanding of this essential cellular quality control process. Their account of the structural and mechanistic basis of chaperone networks has just appeared in the prestigious science journal Nature Communications. These new findings could be harbingers of progress in areas such as vaccine development.
FRANKFURT.
Organisms are constantly invaded by pathogens such as viruses. Our immune
system swings into action to combat these pathogens immediately. The innate
non-specific immune response is triggered first, and the adaptive or acquired
immune response follows. In this second defence reaction, specialised cytotoxic
T lymphocytes known as killer T cells destroy cells in the body that have been
infected and thus prevent damage from spreading. Humans possess a repertoire of
some 20 million T cell clones with varying specificity to counter the multitude
of infectious agents that exist. But how do the killer T cells know where
danger is coming from? How do they recognise that something is wrong inside a
cell in which viruses are lurking? They can't just have a quick peek inside.
At this point, antigen processing comes into play. The process can
be compared to making a road sign. The molecular barcode is “processed" or
assembled in the cell – in the endoplasmic reticulum, to be exact. Special
molecules are used in its making, the MHC class I molecules. They are loaded
with information about the virus invader in a molecular machine, the peptide
loading complex (PLC). This information consists of peptides, fragments of the
protein foreign to the body. These fragments also contain epitopes, the
molecular segments that elicit a specific immune response. During the loading
process, an MHC I-peptide epitope complex thus forms, and this is the road sign
that is then transported to the surface of the cell and presented in a readily
accessible form to the killer T cells – we could almost say that it is handed
to them on a silver platter. The chaperones, special accessory proteins that
assist the correct folding of proteins with complex structures in cells, also
play a significant role.
The chaperones that support antigen processing are calreticulin,
ERp57, and tapasin. But how do they work together? And how important are they
for antigen processing? An answer has now been supplied by a study carried out
by 51ÁÔÆæ Frankfurt and the University of Oxford and published in Nature
Communications. “With this study, we have achieved a breakthrough in our
understanding of cellular quality control," says Professor Robert Tampé,
Director of the Institute of Biochemistry at 51ÁÔÆæ Frankfurt. He
explains the logic underlying this quality control process as follows: “The MHC
I-peptide epitope complex, the road sign, needs to be exceptionally stable, and
for quite a long time, because the adaptive immune response does not start instantly.
It needs 3 to 5 days to get going." So, the sign must not collapse after one
day; that would be disastrous, as the immune defence cells would then fail to
detect cells infected by a virus. This would mean that they would not destroy
these cells and the virus would be able to continue its spread unhindered. A
similar problem would arise if a cell in the body had mutated into a tumour
cell: the threat would remain undetected. It is imperative, therefore, that a
quality control system is in place.
As the study shows, the chaperones are central process components:
they give the road sign the long-term stability it must have by making a strict
selection. By rejecting the short-lived virus fragments in the mass of
available material, they ensure that only MHC I molecules loaded with the best
and most stable peptide epitopes in complex with MHC I are released from
the peptide loading complex. The chaperones have different tasks in this
selection process that is so important for the adaptive immune response, Tampé
says: “Tapasin acts as a catalyst that accelerates the exchange of suboptimal
peptide epitopes for optimal epitopes. Calreticulin and ERp57, in contrast, are
deployed universally." This concerted approach ensures that only stable MHC I
complexes with optimal peptide epitopes reach the cell surface and perform
their role of guiding the killer T cells to the infected or mutated cell.
In what directions does the study point? “We now better understand
which peptides are loaded and how this occurs now. We can also more reliably
predict the dominant peptide epitopes, in other words the stable peptide
epitopes that will be selected by the chaperone network." Tampé hopes that the
new findings will prove useful for developing future vaccines against virus variants.
They could also facilitate progress on future tumour therapies. “Both topics
are directly linked. But the applications in tumour therapy are certainly more
complex and more for the long term."
Publication: Alexander
Domnick, Christian Winter, Lukas Sušac, Leon Hennecke, Mario Hensen, Nicole
Zitzmann, Simon Trowitzsch, Christoph Thomas, Robert Tampé: “Molecular basis of
MHC I quality control in the peptide loading complex" Nature Communications 2022, 13:4701
An image to download
(copyrights Christoph Thomas & Robert Tampé):
Caption: The
mechanism of MHC I assembly, epitope editing and quality control within the
peptide loading complex (PLC). The fully assembled PLC machinery of antigen
processing is formed by the antigen transport complex TAP1/2, the chaperones
calreticulin, ERp57, and tapasin, and the heterodimeric MHC I (heavy and light
chain in teal and green, respectively).
Further information
Institute of Biochemistry
51ÁÔÆæ Frankfurt
Prof. Dr Robert Tampé
Tel: +49 (0)69 79829475
tampe@em.uni-frankfurt.de